January 2021

Tips for managing stress amid winter doldrums and COVID-19 threat.

Economic impact on health care system is unclear after SCOTUS renders decision on Rutledge, Attorney General of Arkansas v. Pharmaceutical Care Management Association.

Telemedicine and remote monitoring advancements can help prevent hospitalizations for the condition.

Push continues for more access to EpiPens, but it is important to protect health care providers who administer the treatment.

A new year is a great time to take on this task, which helps maximize cash flow and contributes to overall patient safety.

Four patient cases involving OTC treatments are presented.

Including them as part of a multidisciplinary team pays dividends for patients.

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Two interactive case studies are presented in the January 2021 issue of Pharmacy Times®.

As care improves, cognitive impairment is likely to be seen earlier in patients with coronary artery disease, diabetes, and HIV.

This activity is supported by an educational grant from CeraVe.

As experts seek to minimize hospitalizations during flu season and a pandemic, reformulated dapsone could offer a cost-effective solution.

This activity is supported by an independent medical education grant from AcelRx Pharmaceuticals, Inc.

Alert practitioners to key strategies to reduce the risk of significant harm to patients.

Patients with HIV who were hospitalized with COVID-19 were found to have high proportions of HIV virologic control on antiretroviral therapy.

Brought to you by The Sassy Pharmacist.

This activity is supported by an educaitonal grant from Boiron USA.

Pfizer’s and Moderna’s receive Emergency Use Authorization in the United States from the FDA.

Board of Pharmacy imposes 1-Year disciplinary license suspension, plus 3 years of probation.

Four generic drugs are featured in the January issue of Pharmacy Times®.

The contributions to patient care through the incorporation of digital clinical pharmacotherapy will help legitimize the role of pharmacists in telehealth.

The FDA has approved Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term treatment of the signs and symptoms of dry eye disease.

During this study, no patient receiving TDF and FTC was admitted to intensive care or died.

Consider these steps for pharmacists to further evolve their role as the pandemic continues to put pressure on the health care system.

Pharmacists can remind patients that seeking treatment helps those around them.

Four prescription products are featured in the January issue of Pharmacy Times®.

Pharmacies must be ready to store, handle, administer, and follow up per local, national, and state regulations.

The study results showed that cabotegravir was 89% more effective than daily oral FTC/TDF for preexposure prophylaxis (PrEP).

During the pandemic, it is important to implement policies and practices that take care of employees.

Four OTC products are featured in the January issue of Pharmacy Times®.